Skip to main navigation Skip to search Skip to main content

Erratum: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: The APAF-CRT mortality trial (European Heart Journal (2021) DOI: 10.1093/eurheartj/ehab569)

  • Michele Brignole
  • , Francesco Pentimalli
  • , Pietro Palmisano
  • , Maurizio Landolina
  • , Fabio Quartieri
  • , Eraldo Occhetta
  • , Leonardo Calò
  • , Giuseppe Mascia
  • , Lluis Mont
  • , Kevin Vernooy
  • , Vincent van Dijk
  • , Cor Allaart
  • , Laurent Fauchier
  • , Maurizio Gasparini
  • , Gianfranco Parati
  • , Davide Soranna
  • , Michiel Rienstra
  • , Isabelle C. van Gelder

Research output: Contribution to journalComment/Letter to the editorAcademic

14 Downloads (Pure)

Abstract

In the originally published version of this manuscript, there were errors in the Table 2 data. In the "Drug (n = 70)" column, in row 5 it should read "8/26 (31%)" instead of "8/28 (29%)" and in row 6 it should read "12/44 (27%)" instead of "12/42 (29%)". These errors have now been corrected online.

Original languageEnglish
Pages (from-to)386
Number of pages1
JournalEuropean heart journal
Volume43
Issue number5
DOIs
Publication statusPublished - 1 Feb 2022

Fingerprint

Dive into the research topics of 'Erratum: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: The APAF-CRT mortality trial (European Heart Journal (2021) DOI: 10.1093/eurheartj/ehab569)'. Together they form a unique fingerprint.

Cite this